Renaissance Technologies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.03M Sell
8,406,169
-1,534,323
-15% -$1.1M 0.01% 1400
2025
Q1
$14.6M Buy
9,940,492
+874,251
+10% +$1.29M 0.02% 815
2024
Q4
$40.2M Buy
9,066,241
+469,043
+5% +$2.08M 0.06% 396
2024
Q3
$35.4M Buy
8,597,198
+25,300
+0.3% +$104K 0.05% 440
2024
Q2
$55.9M Buy
8,571,898
+1,472,097
+21% +$9.6M 0.09% 253
2024
Q1
$61.8M Buy
7,099,801
+503,903
+8% +$4.39M 0.1% 257
2023
Q4
$75.5M Buy
6,595,898
+796,000
+14% +$9.11M 0.12% 197
2023
Q3
$55.9M Buy
5,799,898
+480,445
+9% +$4.63M 0.1% 234
2023
Q2
$56.6M Buy
5,319,453
+681,700
+15% +$7.25M 0.08% 283
2023
Q1
$48.8M Buy
4,637,753
+263,600
+6% +$2.77M 0.06% 357
2022
Q4
$54.2M Sell
4,374,153
-999,000
-19% -$12.4M 0.07% 310
2022
Q3
$55.7M Sell
5,373,153
-42,200
-0.8% -$437K 0.08% 292
2022
Q2
$62.4M Buy
5,415,353
+2,292,300
+73% +$26.4M 0.07% 303
2022
Q1
$39.3M Buy
3,123,053
+443,800
+17% +$5.58M 0.05% 430
2021
Q4
$31.2M Buy
2,679,253
+469,700
+21% +$5.48M 0.04% 497
2021
Q3
$28.9M Sell
2,209,553
-1,228,500
-36% -$16M 0.04% 502
2021
Q2
$44.2M Buy
3,438,053
+297,300
+9% +$3.83M 0.06% 374
2021
Q1
$35.1M Buy
3,140,753
+1,135,000
+57% +$12.7M 0.04% 492
2020
Q4
$22.8M Buy
2,005,753
+1,088,000
+119% +$12.4M 0.02% 692
2020
Q3
$8.26M Sell
917,753
-396,100
-30% -$3.56M 0.01% 1269
2020
Q2
$13.6M Sell
1,313,853
-184,600
-12% -$1.91M 0.01% 1047
2020
Q1
$15.1M Buy
1,498,453
+744,763
+99% +$7.51M 0.01% 925
2019
Q4
$10M Buy
753,690
+667,637
+776% +$8.89M 0.01% 1445
2019
Q3
$739K Buy
+86,053
New +$739K ﹤0.01% 2713
2019
Q2
Sell
-426,799
Closed -$4.84M 3647
2019
Q1
$4.84M Buy
+426,799
New +$4.84M ﹤0.01% 1833
2017
Q3
Sell
-752,522
Closed -$11.9M 3271
2017
Q2
$11.9M Buy
752,522
+529,897
+238% +$8.38M 0.02% 1170
2017
Q1
$3.18M Buy
+222,625
New +$3.18M ﹤0.01% 1981
2016
Q1
Sell
-289,608
Closed -$2.81M 3440
2015
Q4
$2.81M Buy
289,608
+252,292
+676% +$2.45M 0.01% 1889
2015
Q3
$326K Sell
37,316
-45,432
-55% -$397K ﹤0.01% 2741
2015
Q2
$836K Buy
+82,748
New +$836K ﹤0.01% 2536